CD38 and infection: Finally, CD38-targeting monoclonal antibodies (CD38 MAbs) reduce the number of NK and immunosuppressive regulatory T-cells and are associated with a higher number of infections (e.g., increased risk of VZV infection, and a higher risk of hepatitis B virus reactivation) [22, 23].